• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment.

作者信息

Merighi Stefania, Borea Pier Andrea, Varani Katia, Gessi Stefania

机构信息

Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara, Ferrara, Italy.

Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara, Ferrara, Italy.

出版信息

J Invest Dermatol. 2017 Jan;137(1):11-13. doi: 10.1016/j.jid.2016.08.001.

DOI:10.1016/j.jid.2016.08.001
PMID:28010756
Abstract

Purinergic signaling is involved in psoriasis, a chronic skin disease characterized by increased epidermis cell growth. In particular, Andrés et al. focus on the keratinocyte biology modulated by adenosine receptors providing evidence that the A subtype plays a prominent role in the reduction of keratinocyte proliferation whereas A and A agonists have antiinflammatory effects independent of adenosine receptors. The authors report that psoriatic epidermis presents a deregulated adenosine receptor expression profile with reduced A and increased A.

摘要

相似文献

1
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment.
J Invest Dermatol. 2017 Jan;137(1):11-13. doi: 10.1016/j.jid.2016.08.001.
2
Adenosine A and A Receptors Differentially Modulate Keratinocyte Proliferation: Possible Deregulation in Psoriatic Epidermis.腺苷A1和A2受体对角质形成细胞增殖的调节作用不同:银屑病表皮中可能存在失调。
J Invest Dermatol. 2017 Jan;137(1):123-131. doi: 10.1016/j.jid.2016.07.028. Epub 2016 Aug 3.
3
A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.一种用于筛选用于腺苷药物开发的腺苷受体特异性激动剂的新方法。
Sci Rep. 2017 Mar 20;7:44816. doi: 10.1038/srep44816.
4
Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.NG108 - 15细胞中A2a和A2b腺苷受体共表达及脱敏的证据。
Biochem Pharmacol. 1998 Mar 1;55(5):595-603. doi: 10.1016/s0006-2952(97)00466-8.
5
Functional and RNA expression profile of adenosine receptor subtypes in mouse mesenteric arteries.腺苷受体亚型在小鼠肠系膜动脉中的功能和 RNA 表达谱。
J Cardiovasc Pharmacol. 2013 Jan;61(1):70-6. doi: 10.1097/FJC.0b013e318278575e.
6
Antiproliferative effects of selective adenosine receptor agonists and antagonists on human lymphocytes: evidence for receptor-independent mechanisms.选择性腺苷受体激动剂和拮抗剂对人淋巴细胞的抗增殖作用:受体非依赖性机制的证据。
Purinergic Signal. 2013 Sep;9(3):351-65. doi: 10.1007/s11302-013-9354-7. Epub 2013 Jan 29.
7
Adenosine A2a and A2b receptors in cultured fetal chick heart cells. High- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation.培养的鸡胚心脏细胞中的腺苷A2a和A2b受体。与心肌细胞收缩性刺激和环磷酸腺苷(cAMP)积累的高亲和力和低亲和力偶联。
Circ Res. 1995 Feb;76(2):242-51. doi: 10.1161/01.res.76.2.242.
8
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.在中华仓鼠卵巢细胞中表达的人腺苷受体上,腺苷作为激动剂的效力比较。
Biochem Pharmacol. 2001 Feb 15;61(4):443-8. doi: 10.1016/s0006-2952(00)00570-0.
9
Adenosine modulates LPS-induced cytokine production in porcine monocytes.腺苷调节猪单核细胞中 LPS 诱导的细胞因子产生。
Cytokine. 2013 Mar;61(3):953-61. doi: 10.1016/j.cyto.2012.12.026. Epub 2013 Feb 4.
10
Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors.人类和大鼠腺苷A2A受体上激动剂的效价顺序存在差异,但拮抗剂的效价顺序无差异。
Biochem Pharmacol. 1999 Jan 1;57(1):65-75. doi: 10.1016/s0006-2952(98)00298-6.

引用本文的文献

1
Current treatment of Psoriasis triggered by Cytokine Storm and future immunomodulation strategies.细胞因子风暴诱发银屑病的治疗现状与未来免疫调节策略
J Mol Med (Berl). 2024 Oct;102(10):1187-1198. doi: 10.1007/s00109-024-02481-1. Epub 2024 Aug 30.
2
Adenosine and Its Receptors in the Pathogenesis and Treatment of Inflammatory Skin Diseases.腺嘌呤核苷及其受体在炎症性皮肤疾病发病机制和治疗中的作用。
Int J Mol Sci. 2024 May 27;25(11):5810. doi: 10.3390/ijms25115810.
3
Topical Delivery of ROS-Responsive Methotrexate Prodrug Nanoassemblies by a Dissolvable Microneedle Patch for Psoriasis Therapy.
通过一种可溶解的微针贴片递送 ROS 响应型甲氨蝶呤前药纳米组装体用于银屑病治疗。
Int J Nanomedicine. 2023 Feb 18;18:899-915. doi: 10.2147/IJN.S394957. eCollection 2023.
4
Role of Cardiac A Receptors Under Normal and Pathophysiological Conditions.心脏 A 受体在正常及病理生理条件下的作用。
Front Pharmacol. 2021 Jan 26;11:627838. doi: 10.3389/fphar.2020.627838. eCollection 2020.
5
ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.三磷酸腺苷及其代谢物腺苷作为树突状细胞活性的调节剂。
Front Immunol. 2018 Nov 9;9:2581. doi: 10.3389/fimmu.2018.02581. eCollection 2018.
6
Purinergic Signalling: Therapeutic Developments.嘌呤能信号传导:治疗进展
Front Pharmacol. 2017 Sep 25;8:661. doi: 10.3389/fphar.2017.00661. eCollection 2017.